Company intelligence / Profile preview

Elkland Capital

Malvern, Pennsylvania, USA

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Elkland Capital is a private investment firm focused on the healthcare and life sciences sectors, specifically targeting middle-market opportunities in specialty pharmaceuticals, medical devices, and healthcare services. The firm was founded by Peter Lankau, the former President and CEO of Endo Pharmaceuticals, bringing deep operational and strategic expertise to its investment approach. Elkland Capital typically engages in buyouts, recapitalizations, and growth equity investments, leveraging its leadership's extensive industry network to drive value. The firm acts as a strategic partner to its portfolio companies, providing not only capital but also hands-on management guidance to accelerate growth and operational efficiency.

Industry: Investors

Beyond the preview

Go deeper on Elkland Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elkland Capital.

Explore the full profile